CLINICAL TRIALS

CLINICAL EVIDENCE OF Tripterygium wilfordii

Clinical study on effect of Tripterygium wilfordii Hook on uterine leiomyoma
STUDY DESIGN:
Randomized controlled Study.
SUBJECT:
65 women with uterine fibroids
TREATMENT:
Tripterygium wilfordii
DURATION:
6 months
OUTCOMES:
Decrease in volume of fibroids & Uterus, serum estradiol & progesterone

CONCLUSION

Tripterygium Wilfordii Hook may be an effective therapeutic agent for leiomyomas with fewer side effects Tripterygium Wilfordi Hook treatment showed a reversibly inhibitory effect on the ovary. It may be one of the mechanisms of Tripterygium Wilfordii Hook. in decreasing leiomyoma volume
ECGC

CLINICAL EVIDENCE OF (EGCG 45%)

Treatment of symptomatic uterine fibroids with EGCG 45% a pilot randomized
OBJECTIVE:
To evaluate efficacy & safety of epigallocatechin gallate [EGCG] on UF burden and quality of life in women with symptomatic UF
STUDY DESIGN :
Double-blinded placebo-controlled randomized Study
SUBJECT:
11 patients received 800mg of brown rice
this one with treatment placebo group

TREATMENT:
TREATMENT GROUP :
22 patients received 2 capsules of 400mg of green tea extract (45% EGCG)
PLACEBO GROUP:
11 patients received 800mg of brown rice
DURATION:
4 months
OUTCOMES:
Decrease in volume of fibroids, fibroid specific symptom severity, health related quality of life (HRQL), change in Hb

CONCLUSION

EGCG 45% shows promise as a safe and effective therapeutic agent for women with symptomatic UFs. Such a simple, inexpensive, and orally administered therapy can improve women’s health globally.

CLINICAL EVIDENCE OF VITAMIN D3

Vitamin D and the Risk of Uterine Fibroids.2
Donna Day Baird, Michael C. Hill, Joel M. Schectman and Bruce IN. Hollis
STUDY DESIGN :
Controlled Study
SUBJECT RESULT:
674 women with uterine fibroid (459 Blacks, 215 whites)
OUTCOMES:
Association of Vitamin D with prevalence of uterine fibroid.

CONCLUSION

Sufficient vitamin D is associated with a reduced risk of uterine fibroids

TESTIMONIALS